Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 68 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Sarafidis, Pantelis  [Clear All Filters]
Journal Article
Torino, C., Gargani L., Sicari R., Letachowicz K., Ekart R., Fliser D., et al. (2016).  The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study.. Clin J Am Soc Nephrol. 11(11), 2005-2011.
Alexandrou, M. Eleni, Loutradis C., Schoina M., Tzanis G., Dimitriadis C., Sachpekidis V., et al. (2020).  Ambulatory blood pressure profile and blood pressure variability in peritoneal dialysis compared with hemodialysis and chronic kidney disease patients.. Hypertens Res. 43(9), 903-913.
Mykoniatis, I., Sarafidis P., Memmos D., Anastasiadis A., Dimitriadis G., & Hatzichristou D. (2020).  Are endourological procedures for nephrolithiasis treatment associated with renal injury? A review of potential mechanisms and novel diagnostic indexes.. Clin Kidney J. 13(4), 531-541.
Korogiannou, M., Xagas E., Marinaki S., Sarafidis P., & Boletis J. N. (2019).  Arterial Stiffness in Patients With Renal Transplantation; Associations With Co-morbid Conditions, Evolution, and Prognostic Importance for Cardiovascular and Renal Outcomes.. Front Cardiovasc Med. 6, 67.
Alexandrou, M-E., Balafa O., & Sarafidis P. (2020).  Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques.. Am J Nephrol. 51(8), 589-612.
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2019).  Author Correction: Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 15(2), 121.
Loutradis, C., Papadopoulou E., Angeloudi E., Karagiannis A., & Sarafidis P. (2020).  The Beneficial Hemodynamic Actions of SGLT-2 Inhibitors beyond the Management of Hyperglycemia.. Curr Med Chem. 27(39), 6682-6702.
Sarafidis, P., Faitatzidou D., & Papagianni A. (2020).  Benefits and risks of frequent or longer haemodialysis: weighing the evidence.. Nephrol Dial Transplant.
Demosthenous, C., Vlachaki E., Apostolou C., Eleftheriou P., Kotsiafti A., Vetsiou E., et al. (2019).  Beta-thalassemia: renal complications and mechanisms: a narrative review.. Hematology. 24(1), 426-438.
Pappaccogli, M., Labriola L., Van der Niepen P., Pruijm M., Vogt L., Halimi J-M., et al. (2019).  Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views.. Nephrol Dial Transplant. 34(9), 1612-1615.
Sarafidis, P., Loutradis C., Ortiz A., & Ruilope L. M. (2020).  Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT.. Clin Kidney J. 13(3), 287-290.
Pisano, A., Bolignano D., Mallamaci F., D'Arrigo G., Halimi J-M., Persu A., et al. (2020).  Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.. Nephrol Dial Transplant. 35(5), 878-887.
Alexandrou, M-E., Loutradis C., Balafa O., Theodorakopoulou M., Tzanis G., Bakaloudi D., et al. (2020).  A comparative study of ambulatory central hemodynamics and arterial stiffness parameters in peritoneal dialysis and hemodialysis patients.. J Hypertens. 38(12), 2393-2403.
Bikos, A., Angeloudi E., Memmos E., Loutradis C., Karpetas A., Ginikopoulou E., et al. (2018).  A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.. Am J Nephrol. 48(4), 295-305.
Loutradis, C., Schoina M., Dimitroulas T., Doumas M., Garyfallos A., Karagiannis A., et al. (2020).  Comparison of ambulatory central hemodynamics and arterial stiffness in patients with diabetic and non-diabetic CKD.. J Clin Hypertens (Greenwich).
Saratzis, A., Sarafidis P., Melas N., & Khaira H. (2014).  Comparison of the impact of open and endovascular abdominal aortic aneurysm repair on renal function.. J Vasc Surg. 60(3), 597-603.
Papadopoulou, E., Loutradis C., Tzatzagou G., Kotsa K., Zografou I., Minopoulou I., et al. (2020).  Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.. J Hypertens.
Papadopoulou, E., Theodorakopoulou M. P., Loutradis C., Tzanis G., Tzatzagou G., Kotsa K., et al. (2021).  Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus.. Am J Hypertens. 34(4), 404-413.
Sarafidis, P., & Bakris G. (2020).  Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?. Diabetes Care. 43(8), 1684-1686.
Stafylas, P., Kourlaba G., Hatzikou M., Georgiopoulos D., Sarafidis P., & Maniadakis N. (2015).  Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components.. Cost Eff Resour Alloc. 13, 10.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus. Journal of Hypertension. 1.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.. Future Med Chem. 11(11), 1285-1303.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection. Future Medicinal Chemistry. 2019 Jun;11(11):1285-1303.
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές